Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCRX | ELVN | NKTR | ||
| Company | Biocryst Pharma Inc | Enliven Therapeutics Inc | Nektar Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.95 | 51.10 | 68.40 | ||
| High | 9.95 | 51.10 | 68.40 | ||
| Low | 9.95 | 51.10 | 68.40 | ||
| Latest | 9.95 | 51.10 | 68.40 | ||
| Change | +0.04 | +0.23 | +0.08 | ||
| % Change | +0.40% | +0.45% | +0.12% | ||
| Volume | 1,252 | 339 | 1,849 | ||
| 20-Day Average Volume | 6,436,933 | 1,937,242 | 1,239,807 | ||
| Previous Close | 9.91 | 50.87 | 68.32 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.83 | 48.68 | 66.84 | ||
| 20-Day Raw Stochastic | 49.50% | 88.72% | 51.31% | ||
| 20-Day Relative Strength | 54.37 | 62.38 | 50.59 | ||
| Weighted Alpha | +25.94 | +53.60 | +28.41 | ||
| Today's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 24% Buy | ||
| Last Month's Opinion | 40% Buy | 56% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.46% since 07/07/26 | +0.35% since 07/07/26 | -8.68% since 07/07/26 | ||
| Low | 9.80 on 07/13/26 | 48.52 on 07/08/26 | 67.00 on 07/13/26 | ||
| High | 11.22 on 07/09/26 | 52.26 on 07/09/26 | 75.77 on 07/08/26 | ||
| 1-Month | |||||
| %Chg | +14.37% since 06/12/26 | +10.77% since 06/12/26 | +15.19% since 06/12/26 | ||
| Low | 8.70 on 06/15/26 | 40.95 on 06/16/26 | 59.10 on 06/16/26 | ||
| High | 11.22 on 07/09/26 | 52.39 on 06/30/26 | 77.23 on 07/07/26 | ||
| 3-Month | |||||
| %Chg | +2.90% since 04/14/26 | +13.94% since 04/14/26 | -15.83% since 04/14/26 | ||
| Low | 7.78 on 05/06/26 | 33.45 on 06/08/26 | 54.13 on 06/09/26 | ||
| High | 11.22 on 07/09/26 | 52.39 on 06/30/26 | 109.00 on 04/20/26 | ||
| 6-Month | |||||
| %Chg | +46.76% since 01/14/26 | +96.16% since 01/14/26 | +89.53% since 01/14/26 | ||
| Low | 6.23 on 02/05/26 | 24.29 on 01/15/26 | 33.40 on 01/30/26 | ||
| High | 11.22 on 07/09/26 | 52.39 on 06/30/26 | 109.00 on 04/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,518,755 | 3,098,237 | 2,308,259 | ||
| Shares Outstanding, K | 254,163 | 60,905 | 33,786 | ||
| Annual Sales | 874,840,000 | 0 | 55,230,000 | ||
| Annual Net Income | 263,860,000 | -103,690,000 | -164,080,000 | ||
| Last Quarter Sales | 156,410,000 | 0 | 10,860,000 | ||
| Last Quarter Net Income | -721,810,000 | -23,630,000 | -44,900,000 | ||
| 60-Month Beta | 0.55 | 0.24 | 1.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 05/06/26 | -0.38 on 05/07/26 | -1.82 on 05/07/26 | ||
| Earnings Date | 08/03/26 | 08/12/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 8.04 | 0.00 | 0.00 | ||